DOI 10.1158/1078-0432.ccr-25-4836
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.
Аннотация
PURPOSE: BH3 mimetics targeting antiapoptotic BCL2 family proteins are promising therapeutics for T-cell acute lymphoblastic leukemia (T-ALL). However, their activity across genomic subtypes of this cancer and interactions with other antileukemic agents remain incompletely defined.
EXPERIMENTAL
DESIGN
We evaluated the ex vivo sensitivity of BCL2/BCL-XL dual, BCL2-, BCL-XL-, and MCL1-selective inhibitors across 58 xenografts derived from T-ALL, representing diverse molecular subtypes. The BCL2/BCL-XL dual inhibitor AZD4320 was further assessed in combination with selected antileukemic agents. Drug responses were quantified by dose-dependent induction of apoptosis and integrated with genomic and functional analyses.
RESULTS
AZD4320 demonstrated subtype-specific cytotoxicity, with increased sensitivity in early T-cell precursor (ETP)-like T-ALL and resistance in TAL1 αβ-like T-ALL. Gene network analysis revealed subtype-dependent activation of distinct BCL2 family proteins, with AZD4320 response associated with BCL2 and MCL1 activity. Drug-drug interaction analysis using the Multi-dimensional Synergy of Combinations algorithm showed that AZD4320 synergized by potency-rather than maximal efficacy-with asparaginase and dasatinib, particularly broad interaction with asparaginase across subtypes. In vivo, AZD4320-asparaginase combination therapy conferred a survival benefit. Mechanistically, asparaginase-induced asparagine depletion promoted mitochondrial dysfunction, potentiating AZD4320-mediated cytotoxicity.
CONCLUSIONS
These findings highlight the genomic context in shaping BH3 mimetic responses and point to the rational combination of this class of drugs with antileukemic agents such as asparaginase.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.